Bryan R Cullen

USPTO Granted Patents = 14 (Patent Applications = 6)

CIPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 27(Granted Patents)

Company Filing History:

The United States Government As Represented by the Department of Veterans Affairs

patents

4. 1 out of 50

Editas Medicine, Inc.

patents

5. 1 out of 2,925

University of Florida Research Foundation, Incorporated

where one patent can have more than one assignee

Years Active: 1999-2022

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11390861 - CRISPR/cas-related methods and compositions for treating herpes simplex virus (2022-07-19),

2. 10507232 - Materials and methods for the treatment of latent viral infection (2019-12-17),

3. 10286084 - Compositions for the inactivation of virus replication and methods of making and using the same (2019-05-14),

4. 10233451 - Method of regulating gene expression (2019-03-19),

5. 9856476 - Method of regulating gene expression (2018-01-02),

6. 9850485 - Method of regulating gene expression (2017-12-26),

7. 9267145 - Method of regulating gene expression (2016-02-23),

8. 8895524 - Viral microRNA (2014-11-25),

9. 8409796 - Method of regulating gene expression (2013-04-02),

10. 8137910 - Method of regulating gene expression (2012-03-20),

11. 6261772 - Method of assaying for RNA: protein interactions (2001-07-17),

12. 6251675 - Methods utilizing mutant rev genes encoding transdominant repressors of HIV replication (2001-06-26),

13. 6162898 - Mutant Rev transdominant repressors of HIV replication (2000-12-19),

14. 5871958 - Mutant rev genes encoding transdominant repressors of HIV replication (1999-02-16),

Title: Innovations of Bryan R Cullen

Introduction

Bryan R Cullen is a prominent inventor based in Durham, NC (US), known for his significant contributions to the field of genome editing and viral infection treatment. With a total of 14 patents to his name, Cullen has made remarkable strides in developing innovative methods and compositions that address critical health challenges.

Latest Patents

Cullen's latest patents include groundbreaking work on CRISPR/Cas-related methods and compositions for treating herpes simplex virus. This invention focuses on genome editing systems and genetic constructs that target a herpes simplex virus (HSV) viral gene. The systems comprise one Cas9 molecule and a gRNA molecule, along with compositions and cells that utilize these genome editing systems. Additionally, he has developed materials and methods for the treatment of latent viral infections, which are crucial for advancing therapeutic options in this area.

Career Highlights

Throughout his career, Bryan R Cullen has been affiliated with prestigious institutions such as Duke University and Emory University. His work has not only advanced scientific understanding but has also paved the way for new treatment methodologies in virology.

Collaborations

Cullen has collaborated with notable colleagues, including Yan Zeng and E Matthew Kennedy, contributing to a rich environment of innovation and research.

Conclusion

Bryan R Cullen's contributions to the field of genome editing and viral infection treatment exemplify the impact of innovative thinking in addressing complex health issues. His work continues to inspire advancements in medical science and technology.

This text is generated by artificial intelligence and may not be accurate.